US 10208035
Compounds for inhibiting drug-resistant strains of HIV-1 integrase
granted A61KA61K31/4375A61K31/4704
Quick answer
US patent 10208035 (Compounds for inhibiting drug-resistant strains of HIV-1 integrase) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/4375, A61K31/4704, A61K31/496, A61K31/5377